The North America Hollow Fiber Filtration Market should witness market growth of 12.5% CAGR during the forecast period (2022-2028).
Significant investments are being made by many businesses in the development of biologics and biosimilars. More than half of all medication candidates are biologics, such as peptides, monoclonal antibodies, and proteins, in the early stages of the discovery stage. Biologics are expected to generate over half of the total revenue generated by the top 100 pharmaceutical products in the near future.
48 novel biologics and medications were approved by the US Food and Drug Administration (FDA) in 2019. It is anticipated that raising investments by biopharmaceutical sector companies in the development of biologics and biosimilars will increase the number of approved drugs and boost the global output of biopharmaceutical drugs.
Large-molecule therapies, biologics, and biosimilars are all rapidly gaining popularity as novel biologics-based treatments are introduced, despite the fact that small-molecule medications still dominate the worldwide pharmaceuticals business. As a result, the revenue of the current biologics sector grows as well.
Due to the increase in R&D efforts in the biopharma industry, the hollow fiber filtration market is anticipated to expand in this area. Given that hollow fiber filters are widely employed in the pharmaceuticals industry's downstream process, rising R&D activities and the demand for biosimilar products in the U. S. region present lucrative growth potential for the industry. For instance, Thermo Fisher Scientific Inc. committed almost USD 475 million in March 2020 to strengthen its global commercial capabilities and expand its facilities for developing biologics, cell and gene therapy, and medicinal products.
The US market dominated the North America Hollow Fiber Filtration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $382.6 Million by 2028. The Canada market is poised to grow at a CAGR of 15.1% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 14.1% during (2022-2028).
Based on Application, the market is segmented into Protein Concentration & Diafiltration, Cell Culture Harvest & Clarification, Virus or Viral Vector Filtration, Raw Material Filtration, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, CMOs & CROs, and Academic & Research Institutes. Based on Technology, the market is segmented into Microfiltration, Ultrafiltration, and Others. Based on Process, the market is segmented into Reusable and Single-use. Based on Material, the market is segmented into Polyethersulfone (PES), Polysulfone (PS), Mixed Cellulose Ester, Polyvinylidene Difluoride (PVDF), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Repligen Corporation, Sartorius AG, Asahi Kasei Corporation, Meissner Filtration Products, Inc., Danaher Corporation, Merck KGaA, Parker Hannifin Corporation, Cole-Parmer Instrument Company, LLC (Antylia Scientific) (GTCR LLC), Sterlitech Corporation, and Synder Filtration, Inc.
Significant investments are being made by many businesses in the development of biologics and biosimilars. More than half of all medication candidates are biologics, such as peptides, monoclonal antibodies, and proteins, in the early stages of the discovery stage. Biologics are expected to generate over half of the total revenue generated by the top 100 pharmaceutical products in the near future.
48 novel biologics and medications were approved by the US Food and Drug Administration (FDA) in 2019. It is anticipated that raising investments by biopharmaceutical sector companies in the development of biologics and biosimilars will increase the number of approved drugs and boost the global output of biopharmaceutical drugs.
Large-molecule therapies, biologics, and biosimilars are all rapidly gaining popularity as novel biologics-based treatments are introduced, despite the fact that small-molecule medications still dominate the worldwide pharmaceuticals business. As a result, the revenue of the current biologics sector grows as well.
Due to the increase in R&D efforts in the biopharma industry, the hollow fiber filtration market is anticipated to expand in this area. Given that hollow fiber filters are widely employed in the pharmaceuticals industry's downstream process, rising R&D activities and the demand for biosimilar products in the U. S. region present lucrative growth potential for the industry. For instance, Thermo Fisher Scientific Inc. committed almost USD 475 million in March 2020 to strengthen its global commercial capabilities and expand its facilities for developing biologics, cell and gene therapy, and medicinal products.
The US market dominated the North America Hollow Fiber Filtration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $382.6 Million by 2028. The Canada market is poised to grow at a CAGR of 15.1% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 14.1% during (2022-2028).
Based on Application, the market is segmented into Protein Concentration & Diafiltration, Cell Culture Harvest & Clarification, Virus or Viral Vector Filtration, Raw Material Filtration, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, CMOs & CROs, and Academic & Research Institutes. Based on Technology, the market is segmented into Microfiltration, Ultrafiltration, and Others. Based on Process, the market is segmented into Reusable and Single-use. Based on Material, the market is segmented into Polyethersulfone (PES), Polysulfone (PS), Mixed Cellulose Ester, Polyvinylidene Difluoride (PVDF), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Repligen Corporation, Sartorius AG, Asahi Kasei Corporation, Meissner Filtration Products, Inc., Danaher Corporation, Merck KGaA, Parker Hannifin Corporation, Cole-Parmer Instrument Company, LLC (Antylia Scientific) (GTCR LLC), Sterlitech Corporation, and Synder Filtration, Inc.
Scope of the Study
By Application
- Protein Concentration & Diafiltration
- Cell Culture Harvest & Clarification
- Virus or Viral Vector Filtration
- Raw Material Filtration
- Others
By End-user
- Pharmaceutical & Biotechnology Companies
- CMOs & CROs
- Academic & Research Institutes
By Technology
- Microfiltration
- Ultrafiltration
- Others
By Process
- Reusable
- Single-use
By Material
- Polyethersulfone (PES)
- Polysulfone (PS)
- Mixed Cellulose Ester
- Polyvinylidene Difluoride (PVDF)
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Repligen Corporation
- Sartorius AG
- Asahi Kasei Corporation
- Meissner Filtration Products, Inc.
- Danaher Corporation
- Merck KGaA
- Parker Hannifin Corporation
- Cole-Parmer Instrument Company, LLC (Antylia Scientific) (GTCR LLC)
- Sterlitech Corporation
- Synder Filtration, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hollow Fiber Filtration Market, by Application
1.4.2 North America Hollow Fiber Filtration Market, by End User
1.4.3 North America Hollow Fiber Filtration Market, by Technology
1.4.4 North America Hollow Fiber Filtration Market, by Process
1.4.5 North America Hollow Fiber Filtration Market, by Material
1.4.6 North America Hollow Fiber Filtration Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Hollow Fiber Filtration Market by Application
3.1 North America Protein Concentration & Diafiltration Market by Country
3.2 North America Cell Culture Harvest & Clarification Market by Country
3.3 North America Virus or Viral Vector Filtration Market by Country
3.4 North America Raw Material Filtration Market by Country
3.5 North America Others Market by Country
Chapter 4. North America Hollow Fiber Filtration Market by End-user
4.1 North America Pharmaceutical & Biotechnology Companies Market by Country
4.2 North America CMOs & CROs Market by Country
4.3 North America Academic & Research Institutes Market by Country
Chapter 5. North America Hollow Fiber Filtration Market by Technology
5.1 North America Microfiltration Market by Country
5.2 North America Ultrafiltration Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Hollow Fiber Filtration Market by Process
6.1 North America Reusable Market by Country
6.2 North America Single-use Market by Country
Chapter 7. North America Hollow Fiber Filtration Market by Material
7.1 North America Polyethersulfone (PES) Market by Country
7.2 North America Polysulfone (PS) Market by Country
7.3 North America Mixed Cellulose Ester Market by Country
7.4 North America Polyvinylidene Difluoride (PVDF) Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Hollow Fiber Filtration Market by Country
8.1 US Hollow Fiber Filtration Market
8.1.1 US Hollow Fiber Filtration Market by Application
8.1.2 US Hollow Fiber Filtration Market by End-user
8.1.3 US Hollow Fiber Filtration Market by Technology
8.1.4 US Hollow Fiber Filtration Market by Process
8.1.5 US Hollow Fiber Filtration Market by Material
8.2 Canada Hollow Fiber Filtration Market
8.2.1 Canada Hollow Fiber Filtration Market by Application
8.2.2 Canada Hollow Fiber Filtration Market by End-user
8.2.3 Canada Hollow Fiber Filtration Market by Technology
8.2.4 Canada Hollow Fiber Filtration Market by Process
8.2.5 Canada Hollow Fiber Filtration Market by Material
8.3 Mexico Hollow Fiber Filtration Market
8.3.1 Mexico Hollow Fiber Filtration Market by Application
8.3.2 Mexico Hollow Fiber Filtration Market by End-user
8.3.3 Mexico Hollow Fiber Filtration Market by Technology
8.3.4 Mexico Hollow Fiber Filtration Market by Process
8.3.5 Mexico Hollow Fiber Filtration Market by Material
8.4 Rest of North America Hollow Fiber Filtration Market
8.4.1 Rest of North America Hollow Fiber Filtration Market by Application
8.4.2 Rest of North America Hollow Fiber Filtration Market by End-user
8.4.3 Rest of North America Hollow Fiber Filtration Market by Technology
8.4.4 Rest of North America Hollow Fiber Filtration Market by Process
8.4.5 Rest of North America Hollow Fiber Filtration Market by Material
Chapter 9. Company Profiles
9.1 Parker Hannifin Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Sartorius AG
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Merck KGaA
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Asahi Kasei Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Repligen Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Meissner Filtration Products, Inc.
9.7.1 Company Overview
9.8 Sterlitech Corporation
9.8.1 Company Overview
9.9 Cole-Parmer Instrument Company, LLC (Antylia Scientific) (GTCR LLC)
9.9.1 Company Overview
9.10. Synder Filtration, Inc.
9.10.1 Company Overview
Companies Mentioned
- Repligen Corporation
- Sartorius AG
- Asahi Kasei Corporation
- Meissner Filtration Products, Inc.
- Danaher Corporation
- Merck KGaA
- Parker Hannifin Corporation
- Cole-Parmer Instrument Company, LLC (Antylia Scientific) (GTCR LLC)
- Sterlitech Corporation
- Synder Filtration, Inc.
Methodology
LOADING...
